Cargando…

Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?

Detalles Bibliográficos
Autor principal: Wish, Jay B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737340/
https://www.ncbi.nlm.nih.gov/pubmed/31528778
http://dx.doi.org/10.1016/j.ekir.2019.07.004
_version_ 1783450650742358016
author Wish, Jay B.
author_facet Wish, Jay B.
author_sort Wish, Jay B.
collection PubMed
description
format Online
Article
Text
id pubmed-6737340
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67373402019-09-16 Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice? Wish, Jay B. Kidney Int Rep Commentary Elsevier 2019-07-11 /pmc/articles/PMC6737340/ /pubmed/31528778 http://dx.doi.org/10.1016/j.ekir.2019.07.004 Text en © 2019 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Wish, Jay B.
Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?
title Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?
title_full Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?
title_fullStr Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?
title_full_unstemmed Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?
title_short Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?
title_sort will there be a role for a short-acting biosimilar erythropoiesis-stimulating agent in us nephrology practice?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737340/
https://www.ncbi.nlm.nih.gov/pubmed/31528778
http://dx.doi.org/10.1016/j.ekir.2019.07.004
work_keys_str_mv AT wishjayb willtherebearoleforashortactingbiosimilarerythropoiesisstimulatingagentinusnephrologypractice